Introduction. Offspring of obese women have both short-term and long-term increased morbidities. We investigated the relationship between maternal 2-h plasma glucose level determined by an oral glucose tolerance test, degree of obesity, gestational weight gain and total fat, abdominal fat, and fat-free masses in the offspring of obese mothers. Material and methods. Obese mother-newborn dyads were recruited and 2-h plasma glucose levels were assessed during gestational weeks 27-30; neonatal body composition was measured by dualenergy X-ray absorptiometry scanning (DXA) within 48 h of birth. Results. Among 264 term, healthy, and singleton infants eligible for inclusion, 248 were included. Of these, 205 (83%) obese mother-newborn dyads had a DXA scan and 2-h plasma glucose measurements. Linear regression analysis showed that birthweight z-scores correlated with 2-h plasma glucose levels (p = 0.002) after adjusting for gestational weight gain, maternal age, education, smoking, prepregnancy degree of obesity, parity, and birth length. Total (p = 0.012) and abdominal (p = 0.039) fat masses correlated with 2-h plasma glucose levels after adjusting for gestational weight gain, maternal age, education, smoking, prepregnancy degree of obesity, parity, gestational age, and newborn sex. There was no association between total (p = 0.88) and abdominal (p = 0.61) fat-free masses and 2-h plasma glucose. Conclusion. At 27-30 weeks of gestation, 2-h plasma glucose levels are related to total and abdominal newborn fat masses, but not to fat-free mass. Interventions targeting maternal postprandial glucose levels may induce more appropriate birthweight, thereby reducing the risk of subsequent morbidity. Abbreviations: 2-h glucose, 2-h level of plasma glucose in mmol/L; BMI, body mass index; DXA, Dual-energy X-ray absorptiometry; GWG, gestational weight gain; HAPO, Hyperglycemia and Adverse Pregnancy Outcome; TOP, Treatment of Obese Pregnant. ª 2015 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 95 (2016) 429-435
Introduction
Prepregnancy obesity is associated with short-term and long-term adverse effects on the child (1, 2) . Prepregnancy obesity and excessive gestational weight gain (GWG) are related to increased risk of macrosomia. Perinatal complications and morbidity, such as higher rates of caesarean section, asphyxia, shoulder dystocia and hypoglycemia, are related to macrosomia (3) . In addition, the children of obese women have a higher incidence of congenital malformations (4) . Finally, this group of infants has increased risk over time of developing metabolic diseases, with subsequent obesity, hypertension, arteriosclerosis, and type II diabetes (5) (6) (7) .
Prepregnancy body mass index (BMI) and GWG influence newborn body composition. The fat mass is higher in the offspring of prepregnancy obese mothers and fat mass increases with excessive GWG (8) (9) (10) .
Maternal plasma glucose is associated with fetal body composition, as demonstrated in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study (11) , which examined a cohort of approximately 17 000 normal weight and obese mother-newborn dyads. A linear association between newborn fat and fat-free masses and maternal postprandial glucose levels during pregnancy was demonstrated. Prepregnancy obesity and excessive GWG increase the risk of developing gestational hyperglucosmia secondary to higher insulin resistance. The HAPO study did not include GWG in the analyses, which is also known to influence newborn fat mass.
The aim of this study was to evaluate the relationship between newborn body composition and maternal obesity, GWG, and 2-h plasma glucose obtained after an oral glucose tolerance test performed in the third trimester.
Material and methods
We included singleton, healthy, and term (>258 days of gestation) infants with a postnatal age <48 h. Infants were recruited between 10 December 2010 and 30 June 2012. All mothers had participated in the Treatment of Obese Pregnant (TOP) study at Hvidovre Hospital, Copenhagen, Denmark. The inclusion criterion for the TOP study was a prepregnancy BMI ≥30 kg/m². The women were encouraged to limit GWG to <5 kg. In the TOP study, 425 mothers were randomized into three groups: PA + D: exercise and diet, PA: exercise, or C: control (12) .
The present study began when 135 women had already given birth. Not all TOP study participants were therefore eligible for inclusion in our study. Those excluded were mothers with chronic diseases or preeclampsia, which may have restricted intrauterine growth, and infants requiring admission to the neonatal intensive care unit or infants suffering from congenital malformations.
Written informed consent was obtained from both parents before infants were included. The study was approved by the Ethics Committee of the Capital Region of Denmark (H-D-2008-119) and registered at www.clinicaltrials.gov (NCT01235663).
Maternal and infant data
We obtained information on maternal social status, smoking, exercise habits, and number of previous pregnancies through a questionnaire filled in during the first trimester. Gestational length was determined by a routine ultrasound examination at the Department of Obstetrics at 11-13 weeks of gestation. Prepregnancy weight was self-reported, and all women were weighed at gestational age 36-37 weeks. GWG was calculated as the difference between weight at 36-37 weeks of gestation and prepregnancy weight. Women were weighed in light clothing without shoes on a digital scale (Seca Scales, Hamburg, Germany). BMI was calculated from weight/height 2 (kg/m 2 ).
Recumbent infant weight (Seca 727, Digital Baby Scales, Germany), length, and head circumference were measured with a nonstretchable measuring tape according to World Health Organization guidelines (13) . The estimated birthweight, adjusted for gestational age and sex, was calculated according to Marsal et al. (14) , and differences between the actual and the estimated birthweights are presented as z-scores. Large for gestational age were defined as birthweight z-score >2.
Standard oral glucose tolerance test
The 2-h level of plasma glucose (2-h glucose; mmol/L) was assessed by a 75-g 2-h oral glucose tolerance test during gestational weeks 27-30. In Denmark, gestational diabetes is defined as 2-h glucose >8.9 mmol/L (15) .
Key Message
Analyses evaluating the effect of maternal glucose levels and gestational weight gain on regional newborn tissue composition are missing. Newborn fat mass is associated with both maternal glucose levels and gestational weight gain. Prepregnancy obesity has greater influence on abdominal fat mass than total fat mass.
Body composition assessment
Infant body composition was assessed using dual-energy X-ray absorptiometry (DXA) scanning (DXA, Hologic Discovery A, Bedford, MA, USA) within 48 h after birth. This method calculates fat-free body mass, total fat mass, and bone mass with use of pediatric software. A wholebody scan yields a radiation dose of 10.5 lSv, equivalent to 1-2 days of background radiation. The quality criteria when evaluating the scans were identical to those of Cooke et al. (16) .
Two boxes were drawn using the PEDIATRIC DXA software to estimate fat mass and fat-free mass in the abdomen. The thoracic diaphragm and both upper iliac crests limited the first box, whereas the second box was restricted by both upper iliac crests and the femoral heads ( Figure 1 ). Fat % was calculated as fat mass/total mass. Abdominal fat/fat-free ratio was calculated as abdominal fat mass/abdominal fat-free mass. From duplicate scans in 58 infants, the test-retest variabilities for DXA-derived fat and fat-free masses were calculated to 11.8 and 7.1%, respectively (17) .
Statistical analysis
Descriptive statistics were calculated for all outcome variables and presented as means and standard deviations for normally distributed data, and as median and range for not-normally distributed data. Differences between groups were analyzed by the Student's t-test.
GWG was used as a continuous variable, although categorized in the tables according to recommendations of the Institute of Medicines (18) . Multiple linear regressions tested birthweight z-score, total fat mass, fat-free mass, fat %, abdominal fat and abdominal fat-free masses, and abdominal fat/fat-free ratio against prepregnancy obesity (continuous variable, BMI ≥30 kg/m 2 ), GWG (continuous variable), and 2-h plasma glucose after adjusting for maternal age, education, smoking, parity, and newborn length. Because birthweight z-scores were already adjusted for gestational age and sex, these predictors were only incorporated in the DXA data analysis. Indicator variables for TOP study randomization were included to evaluate any effect of exercise or diet during pregnancy. The level of significance was set to <0.05, and all analyses were performed using SPSS version 19 (IBM Corp., Armonk, NY, USA).
Results
Details regarding inclusion in the study are provided in Figure 2 . We included 205 mother-newborn dyads ( Table 1 ). Five of the study participants developed gestational diabetes, and in all women the plasma glucose normalized on diet alone. Diabetic mothers' offspring had mean birthweights and fat % similar to those of the offspring of nondiabetic mothers (3560 g vs. 3705 g; p = 0.40 and 9.6% vs. 11.4%; p = 0.37).
Birthweight z-score was associated with 2-h glucose (p = 0.002) and GWG (p < 0.001), whereas prepregnancy degree of obesity was not (p = 0.092). Newborn total fat mass was associated with 2-h glucose (p = 0.012): per increase in unit glucose, the fat mass increased by 30.2 g. Total fat mass was also associated with GWG (p < 0.001): per 10-kg increase in GWG, the newborn accumulated a mean of 133 g fat.
Fat-free mass, however, was only associated with GWG (p = 0.027); per 10-kg increase in GWG, the amount of newborn fat-free mass increased with a mean of 97 g ( Table 2 ).
Newborn abdominal fat mass was related to 2-h glucose (p = 0.039): per increase in unit glucose, abdominal fat mass increased by 3.6 g. GWG (p < 0.001) and prepregnancy degree of obesity (p = 0.019) were also associated with the amount of abdominal fat mass: per 10-kg increase in GWG, the newborn had on average 16 g more abdominal fat, and per increase in unit BMI, the amount of abdominal fat increased by 1.3 g.
Abdominal fat-free mass was only associated with GWG (p = 0.004); per 10-kg increase in GWG, the newborn gained 46 g abdominal fat-free mass ( Table 3) .
TOP study intervention had no influence on either birthweight z-score or body composition.
Discussion
Our study focused on the association between 2-h glucose values and birthweight and neonatal body composition. We observed that birthweight z-score increased with higher levels of 2-h glucose, and this overgrowth was the result of global fat accumulation as well as abdominal fat accumulation. Notably, the relation between 2-h glucose values and newborn fat mass was present in a graded fashion across the whole spectrum of maternal glycemia, and therefore maternal glucose levels in nondiabetic obese mothers should also be considered as a factor of importance when examining fetal growth.
Normally, 2-h plasma glucose is maintained within narrow limits after a standardized glucose load, and high glucose levels indicate a decreased sensitivity to insulin if type I diabetes can be excluded. Pregnancy induces partial insulin resistance, and this risk increases with obesity, resulting in higher plasma glucose levels. When developing manifest gestational diabetes, there is also a lower secretion of insulin from the pancreas (19, 20) . Glucose readily crosses the placenta and induces fetal hyperinsulinemia, which enhances fetal growth. This theory was originally proposed by Pedersen in 1952 (21) and has been supported by the HAPO study (11) .
Due to its anabolic action, accretion of fat-free tissues should be anticipated from insulin (22) , but apparently this effect is very modest in fetal hyperinsulinemia; we were unable to establish any relation between DXAderived newborn fat-free mass and 2-h glucose (total fatfree mass p = 0.88 and abdominal fat free mass p = 0.61). Fetal energy expenditure consists primarily of glucose, whereas fetal anabolic actions on fat-free masses come from protein neo-synthesis (23) . Therefore, we hypothesized that high maternal glucose levels induce fetal hyperinsulinemia, resulting in fat mass accumulation, whereas fat-free mass remains constant. This finding is in contrast to the HAPO study in which newborn fatfree mass was associated with maternal glycemia. The HAPO study did not include GWG in the analysis, and fat-free mass was calculated from formulae based on birthweight and skinfold thickness (11) and not directly from DXA scans. The 2-h glucose and GWG influenced total fat mass independently, and both factors may have a central role in regulating fetal growth. GWG is a strong predictor of newborn fat mass, as shown in the Southampton Women's Survey study (10) . Therefore, the effects of prophylactic measures directed against fetal macrosomia that involve reducing maternal BMI, minimizing GWG, and increasing maternal exercise load may not be the same on fetal tissue composition.
We found that an increase in abdominal fat mass was related to prepregnancy obesity, GWG, and 2-h glucose, whereas total fat mass was only related to GWG and 2-h glucose. There was, however, a tendency towards both total fat mass (p = 0.071) and fat percentage (p = 0.070) being associated with prepregnancy obesity. The lack of significance might be due to a type 2 error.
Quantification of abdominal fat mass is less exact than quantification of total fat mass because of the smaller area involved. Nevertheless, our study indicates that prepregnancy obesity is a strong determinant of abdominal fat mass. Tanvig et al. found a positive association between newborn abdominal circumference and maternal prepregnancy obesity when examining a large cohort consisting of approximately 300 000 babies (24) . We have previously shown that in newborn babies abdominal circumference is associated with amount of abdominal fat mass (25) . The correlation between prepregnancy obesity and newborn abdominal tissue composition may be mediated through maternal metabolic imbalances to which insulin resistance is one of the contributors. Our data were explored for any possible interactions between 2-h glucose and prepregnancy degree of obesity and GWG, but none were present (data not shown).
Assessment of abdominal fat tissue using DXA does not distinguish between visceral and subcutaneous tissue components, and for this purpose, MRI is the reference standard (26) . MRI in newborns is, however, logistically challenging and therefore difficult to perform in larger cohorts. On the other hand, air displacement plethysmography has been shown to estimate fat mass more precisely than DXA, but the method gives no opportunity for assessment of regional body composition (27) . Our cohort was recruited from the interventional TOP study. The group of infants is homogeneous, which reduces the risk of bias but lowers the external validity of our findings. Although the maternal pregnancy intervention did not affect birthweight z-score or body composition, a general awareness regarding lifestyle issues may be elevated in the cohort. Because of both missing DXA scans and 2-h glucose values, our cohort was reduced to 205 mother-newborn dyads. One of our inclusion criteria was maternal BMI >30 kg/m 2 , and this may impose limits because of the restricted variance of the variable, but also underlines the impact of our findings. It would have strengthened our findings if we have had included a reference group consisting of prepregnancy normal weight women and their offspring.
Conclusions
Newborn birthweight z-score and total and abdominal fat masses are associated with maternal 2-h glucose values obtained in gestational weeks 28 to 30. There is no correlation between 2-h glucose values and fat-free mass. Our data indicate that the degree of prepregnancy obesity has a greater influence on newborns' abdominal fat mass than the total fat mass. 
